IVF NASDAQ
INVO Fertility, Inc.
1W: -9.5%
1M: -15.3%
3M: -37.1%
YTD: -81.0%
1Y: -97.2%
3Y: -99.9%
5Y: -100.0%
$0.85
-0.05 (-5.06%)
Weekly Expected Move ±6.1%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.5M
52W Range0.8115-84.4
Volume222,369
Avg Volume3,159,816
Beta2.35
Dividend—
Analyst Ratings
Company Info
CEOSteven Shum
Employees41
SectorHealthcare
IndustryMedical - Devices
IPO Date2020-11-02
Websiteinvofertility.com
5582 Broadcast Court
Sarasota, FL 34240
US
Sarasota, FL 34240
US
978 878 9505
About INVO Fertility, Inc.
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
Latest News
INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability
INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure
INVO Fertility receives Nasdaq notice over delayed SEC filings
INVO Fertility Announces Fiscal Year 2025 Financial Results
INVO Fertility Announces Fiscal Year 2025 Financial Results
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Krigsvold Terah Rene | 0 | — | 2025-12-30 | |
| Krigsvold Terah Rene | 4,375 | $8.96 | 2025-12-30 | |
| Krigsvold Terah Rene | 11 | $2,119.68 | 2025-12-30 | |
| Krigsvold Terah Rene | 3 | $17,280.00 | 2025-12-30 | |
| Krigsvold Terah Rene | 3 | $17,683.20 | 2025-12-30 |